Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 12/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARD | Q03181 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15047639 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL2213923 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL2283334 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL9718424 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL9442148 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL7567415 | 1.00 | GPR84 (0.47) | GPR84NOD1PPARGPPARDPPARA | |
| Carbamic Acid SCHEMBL2289549 | 0.95 | NOD1 (0.46) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL19852728 | 0.93 | GPR84 (0.44) | GPR84NOD1PPARGPPARDPPARA | |
| SCHEMBL31321524 | 0.93 | GPR84 (0.44) | GPR84NOD1PPARGPPARDPPARA | |
| Hydrochloric Acid SCHEMBL3914766 | 0.91 | GPR84 (0.40) | GPR84NOD1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180311316-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | ADOCIA (FR) | 2018-11-01 | — | — | US | claimed |
| US-20170182131-A9 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | ADOCIA (FR) | 2017-06-29 | — | — | US | claimed |
| EP-2741765-B9 | INJECTABLE SOLUTION OF AT LEAST ONE TYPE OF BASAL INSULIN | ADOCIA (FR) | 2016-09-28 | — | — | EP | claimed |
| EP-2741765-B1 | INJECTABLE SOLUTION OF AT LEAST ONE TYPE OF BASAL INSULIN | ADOCIA (FR) | 2016-03-30 | — | — | EP | claimed |
| US-20150250858-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | ADOCIA (FR) | 2015-09-10 | — | — | US | claimed |
| US-9089476-B2 | Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5 | ADOCIA (FR) | 2015-07-28 | — | — | US | claimed |
| US-20130065826-A1 | Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 | ADOCIA (FR) | 2013-03-14 | — | — | US | claimed |
| US-20120309680-A1 | Functionalized oligosaccharides | ADOCIA (FR) | 2012-12-06 | — | — | US | claimed |
| US-20230242475-A1 | Compositions Containing Dialkyl Amino Acid Ester Salts | STEPAN CO (US) | 2023-08-03 | — | — | US | disclosed |
| EP-4211107-A1 | COMPOSITIONS CONTAINING DIALKYL AMINO ACID ESTER SALTS | Stepan Company (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022056366-A1 | COMPOSITIONS CONTAINING DIALKYL AMINO ACID ESTER SALTS | STEPAN COMPANY (US) | 2022-03-17 | — | — | WO | disclosed |
| CN-113730555-A | Injectable solution of basal insulin and substituted copoly (amino acid) having pH7 and at least PI 5.8 to 8.5 | 阿道恰公司 | 2021-12-03 | — | — | CN | disclosed |
| CN-109640953-B | Injectable solutions comprising copolymerized amino acids with carboxylate charge and hydrophobic groups | 阿道恰公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-109379888-B | Injectable solutions comprising copolymerized amino acids with carboxylate charge and hydrophobic groups | 阿道恰公司 | 2021-10-29 | — | — | CN | disclosed |
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | ADOCIA (FR) | 2013-09-19 | — | — | US | disclosed |
| US-20130178415-A1 | Injectable solution at pH 7 comprising at least one basal insulin the PI of which is between 5.8 and 8.5 and a substituted co-polyamino acid | ADOCIA (FR) | 2013-07-11 | — | — | US | disclosed |
| US-20130065826-A1 | Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 | ADOCIA (FR) | 2013-03-14 | — | — | US | disclosed |
| US-20120309680-A1 | Functionalized oligosaccharides | ADOCIA (FR) | 2012-12-06 | — | — | US | disclosed |
| US-20110195913-A1 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer | ADOCIA (FR) | 2011-08-11 | — | — | US | disclosed |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | ADOCIA (FR) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170182131-A9 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | IAPP, IGFBP5, INSR | GPR84 3987/4885NOD1 1075/4885PPARG 503/4885 |
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | CD44, B3GAT3, UGCG | GPR84 2444/4885NOD1 602/4885PPARG 350/4885 |
| US-20180311316-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | IAPP, IGFBP5, INSR | GPR84 3987/4885NOD1 1075/4885PPARG 503/4885 |
| US-20150250858-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | IAPP, IGFBP5, INSR | GPR84 3987/4885NOD1 1075/4885PPARG 503/4885 |
| US-20110195913-A1 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer | CD44, CSGALNACT1, ALG1 | GPR84 3376/4885NOD1 981/4885PPARG 2303/4885 |
| US-20130178415-A1 | Injectable solution at pH 7 comprising at least one basal insulin the PI of which is between 5.8 and 8.5 and a substituted co-polyamino acid | IAPP, VIP, IGFBP1 | GPR84 1243/4885NOD1 1669/4885PPARG 885/4885 |
| US-20230242475-A1 | Compositions Containing Dialkyl Amino Acid Ester Salts | DGKA, MGLL, DGKG | GPR84 289/4885NOD1 4879/4885PPARG 1232/4885 |
| US-20120309680-A1 | Functionalized oligosaccharides | OSTC, STT3A, DDOST | GPR84 1185/4885NOD1 595/4885PPARG 4647/4885 |
| US-20130065826-A1 | Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 | IAPP, IGFBP5, INSR | GPR84 3987/4885NOD1 1075/4885PPARG 503/4885 |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | BMP1, BMP2, BMP6 | GPR84 2454/4885NOD1 648/4885PPARG 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.